PARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of data from a real-world survey of patients taking AUSTEDO XR® (deutetrabenazine) extended-release tablets. Patients taking AUSTEDO XR reported increased social and emotional well-being as…
Austin, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Venous Stents Market Size & Growth Analysis: According to SNS Insider, the global Venous Stents Market size was valued at USD 1.36 billion in 2025 and is projected to reach USD 2.57 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.36% over the…
Convinced that positive impact is a driving force for both the company and society, the Bonduelle Group is proud to announce that it has obtained international B CorpTM certification worldwide. This significant milestone propels Bonduelle into the very select circle of French groups with B Corp certification and contributes to its ambition to serve a…
Boulder, CO, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Healthy Gut, a Boulder-based digestive health company, announced the release of an updated formulation of its Holozyme product, reflecting the company’s expanded focus on fructan sensitivity as a potential contributor to bloating among individuals who follow plant-forward or health-conscious diets.
SINGAPORE, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center (Health-ISAC) is pleased to announce the appointment of Paul Chua as its new Asia Pacific (APAC) Operations Director.
TEL AVIV, Israel, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present its ongoing transformation and expected growth trajectory through 2030 at the 44th Annual J.P. Morgan Healthcare Conference. Teva’s President and Chief Executive Officer, Richard Francis, will meet with investors and present the Company’s milestones achieved in…
